Morgen Shaff
Surgical · Parker, CONPI 1396873105
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 197 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,348 and has fallen 62.2% since, to $509 in 2025. Among surgical clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 197 payments — averaging $20.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$731
- Collegium Pharmaceutical, Inc.$627
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$443
- Ipsen Biopharmaceuticals, Inc$306
- Boston Scientific$250
- Biohaven Pharmaceutical Holding Company Ltd.$225
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,986100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 26 | $731 |
| Collegium Pharmaceutical, Inc. | 43 | $627 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 32 | $443 |
| Ipsen Biopharmaceuticals, Inc | 13 | $306 |
| Boston Scientific | 9 | $250 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $225 |
| Amgen | 7 | $207 |
| Nevro Corp. | 4 | $190 |
| Scilex Pharmaceuticals Inc. | 10 | $153 |
| Merz Pharmaceuticals, LLC | 5 | $107 |
| Bioventus LLC | 7 | $101 |
| GRT US Holding, Inc. | 5 | $93 |
| Saluda Medical Americas, Inc. | 4 | $74 |
| SPR Therapeutics, Inc | 3 | $68 |
| USWM, LLC | 3 | $51 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| Almatica Pharma LLC | 4 | $50 |
| Idorsia Pharmaceuticals US Inc | 3 | $43 |
| Redhill Biopharma Inc. | 3 | $40 |
| Vertex | 1 | $35 |
| Zimmer Biomet | 1 | $24 |
| Medline Industries LP | 1 | $21 |
| Averitas Pharma Inc. | 1 | $21 |
| Biodelivery Sciences International, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| Novartis | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$124
- BOTOX$124
How this compares
$3,986 in reported general payments places this provider in the 90th percentile of 495 surgical providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nucynta ErTapentadol Hcl | 21 | $24,928 |
| Nurtec OdtRimegepant Sulfate | 12 | $23,077 |
| MovantikNaloxegol Oxalate | 44 | $17,651 |
| NucyntaTapentadol Hcl | 18 | $14,551 |
| Oxycodone Hcl | 432 | $9,352 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 299 | $9,350 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 209 | $8,978 |
| OxycontinOxycodone Hcl | 23 | $6,997 |
| Xtampza ErOxycodone Myristate | 15 | $6,135 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 27 | $5,642 |
| Topiramate ErTopiramate | 12 | $5,349 |
| Morphine Sulfate ErMorphine Sulfate | 173 | $5,165 |
| BelsomraSuvorexant | 11 | $5,008 |
| Fentanyl | 53 | $4,960 |
| Pregabalin | 153 | $3,352 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta Er, Nucynta, Xtampza Er | $627 | $45,61454 claims |
| Redhill Biopharma Inc.Movantik | $40 | $17,65144 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 495 surgical providers in Colorado.
Other surgical in Parker
- Michael WellsAurora$26K
- Charles EttelsonDenver$24K
- Joshua CrossLakewood$17K
- Mitchell EricksonAurora$16K
- Tim FilzenColorado Springs$13K
- Charles JenningsThornton$9K
- Joshua KatzDenver$8K
- Jordyn AlmeidaDenver$8K
- Nicole KenyonDenver$7K
- Yasmeen BierwirthBoulder$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.